infection (1) . There is a slight predominance of methicillin sensitive species (MSSA) compared to methicillin resistant species (MRSA). Morbidity and mortality are both high, with over 80% of patients requiring care in the ICU, and a fatality rate of 13% (2).
Among patients admitted to the intensive care unit with a primary diagnosis of influenza, there is a 15% incidence of S. aureus pneumonia. Risk factors for co-infection in this setting include obesity, HIV infection, and immunosuppressive medication. There is a robust association between bacteremia and mortality (3). Early empiric antibiotic therapy with an agent active against S. aureus should be strongly considered for patients admitted to the ICU with influenza complicated by pneumonia, pending the return of blood and respiratory cultures.
